Catherine E. Lucasey
Gründer bei TVAX BIOM
Profil
Catherine E.
Lucasey is the founder of TVAX Biomedical, Inc. (founded in 2011) and TVAX Biomedical I LLC (founded in 2004), where she holds the titles of Director, VP-Communications & Marketing and Director-Communications & Marketing, respectively.
Ms. Lucasey's former job was as Manager-Endocrine Division at the University of Kansas from 1990 to 2011.
Ms. Lucasey received undergraduate and graduate degrees from Webster University.
Aktive Positionen von Catherine E. Lucasey
| Unternehmen | Position | Beginn |
|---|---|---|
| TVAX BIOM | Gründer | 14.07.2011 |
| TVAX Biomedical I LLC | Gründer | 01.11.2004 |
Ehemalige bekannte Positionen von Catherine E. Lucasey
| Unternehmen | Position | Ende |
|---|---|---|
| University of Kansas | Corporate Officer/Principal | 01.08.2011 |
Ausbildung von Catherine E. Lucasey
| Webster University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
TVAX Biomedical, Inc.
 TVAX Biomedical, Inc. BiotechnologyHealth Technology TVAX Biomedical, Inc. manufactures and sells healthcare products. It is a biotechnology company, which focuses on the development of targeted cell-based immunotherapies for the treatment of cancer and is performing clinical trials with specific focus on brain cancers. The firm’s proprietary immunologic treatment, TVAX Immunotherapy, uses a patient's cells to create activated, genetically unique cancer-killing T cells that can destroy the patient's cancer cells, including cancer stem cells, which are widely believed to be responsible for cancer growth, spread and metastasis. The company was founded by Gray W. Wood, Frank P. Holladay, Catherine E. Lucasey and Lowell Lynn Tilzer on July 14, 2011 and is headquartered in Lenexa, KS. | Health Technology |
| TVAX Biomedical I LLC |
